⌘K

Home/Filings/4/0001250853-14-000049

4//SEC Filing

Kindred Biosciences, Inc. 4

Accession 0001250853-14-000049

CIK 0001561743operating

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 9:54 PM ET

Size

5.2 KB

Accession

0001250853-14-000049

Insider Transaction Report

Form 4

Period: 2014-02-03

Kindred Biosciences, Inc.KIN

GALLIKER STEPHEN S

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2014-02-03+50,000→ 50,000 total
Exercise: $15.41Exp: 2024-02-03→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option will vest as to 50% upon date of grant and 50% on February 3, 2015.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Kindred Biosciences, Inc.

CIK 0001561743

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001561743

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 9:54 PM ET
Size: 5.2 KB

View on SEC.gov